Jove
Visualize
Contact Us

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Labeling DNA Probes03:31

Labeling DNA Probes

8.2K
DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
8.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-Tumor Activity of Cdk2/9 Inhibitor Fadraciclib in an In Vivo Model of Temozolomide Refractory Neuroblastoma.

Molecular cancer therapeutics·2026
Same author

On the Scope of DCAF1-Recruiting PROTACs Degrading Protein Kinases.

Journal of medicinal chemistry·2026
Same author

Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategies.

Nature reviews. Drug discovery·2026
Same author

Nanoscale Direct-to-Biology Optimization of Cdk2 Inhibitors.

Journal of medicinal chemistry·2026
Same author

Human DEAH-box helicase 8 regulates HSF1-mediated stress response and cancer-associated pre-mRNA splicing in tumour cells.

NAR cancer·2026
Same author

Discovery and Characterization of Divarasib (GDC-6036), a Potent Covalent Inhibitor of KRAS G12C.

Journal of medicinal chemistry·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 16, 2025

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling
10:49

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling

Published on: September 20, 2016

12.7K

Which Small Molecule? Selecting Chemical Probes for Use in Cancer Research and Target Validation.

Mary M Mader1,2, Joachim Rudolph2,3, Ingo V Hartung2,4

  • 1Indiana Biosciences Research Institute, Indianapolis, Indiana.

Cancer Discovery
|September 15, 2023
PubMed
Summary

High-quality chemical probes are crucial for cancer research. This study outlines best practices for selecting and using these tools to ensure accurate results and avoid misleading conclusions in disease research.

More Related Videos

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Published on: November 1, 2019

8.3K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K

Related Experiment Videos

Last Updated: Jul 16, 2025

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling
10:49

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling

Published on: September 20, 2016

12.7K
Kinetic Screening of Nuclease Activity using Nucleic Acid Probes
06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Published on: November 1, 2019

8.3K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K

Area of Science:

  • Chemical Biology
  • Molecular Oncology

Background:

  • Small-molecule chemical probes are vital tools in cancer research, complementing molecular biology techniques for protein function exploration.
  • Improper selection and utilization of these reagents can lead to erroneous conclusions.
  • Novel drug modalities, such as protein degraders, present unique challenges for tool development.

Purpose of the Study:

  • To provide best practices for selecting, validating, and using high-quality chemical probes in cancer research.
  • To illustrate examples of inadequate chemical tools and their potential pitfalls.
  • To offer guidance for researchers in identifying appropriate small-molecule probes, especially for novel therapeutic strategies.

Main Methods:

  • Review and illustration of examples of poor chemical tools.
  • Formulation of best practices for chemical probe selection and validation.
  • Discussion of complexities related to novel drug modalities like protein degraders.

Main Results:

  • Identification of common pitfalls in the use of chemical probes.
  • Establishment of criteria for evaluating chemical probe quality, including potency, selectivity, and target engagement.
  • Highlighting the importance of interdisciplinary collaboration and resource awareness.

Conclusions:

  • Adherence to best practices in chemical probe selection and use is essential for robust cancer research.
  • Improved understanding and application of chemical probes enhance biological target validation and pathway analysis.
  • Collaboration and awareness of resources are key to reducing misleading data and increasing research productivity.